Clinical Trials Browser

Interventional × Neoplasm Metastasis × BID protein, human × Clear all

NCT02029001 2025-08-07

MOST plus

Phase 2 Recruiting

Neoplasm Metastasis

NCT01976741 2021-05-06

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Phase 1 Completed

168 enrolled 59 charts

GenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02101684 2018-03-05

Greko II

Phase 2 Terminated

Granulosa Cell Tumor, Neoplasm Metastasis